Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1359853rdf:typepubmed:Citationlld:pubmed
pubmed-article:1359853lifeskim:mentionsumls-concept:C2698602lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0034340lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0251211lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0439962lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0410539lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C2675746lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C1413247lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C2256670lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:1359853lifeskim:mentionsumls-concept:C0057764lld:lifeskim
pubmed-article:1359853pubmed:issue7lld:pubmed
pubmed-article:1359853pubmed:dateCreated1992-12-23lld:pubmed
pubmed-article:1359853pubmed:abstractTextMale Sprague-Dawley rats were treated with an LD20, LD50 and LD80 respectively, of tetra-, penta-, hexa-, hepta-CDD and a mixture of the four CDDs, all carrying chlorine substituents in the biologically crucial 2, 3, 7, and 8 positions. Specific activities of two key enzymes of gluconeogenesis, viz, phosphoenolpyruvate carboxykinase (PEPCK) and pyruvate carboxylase (PC), as well as the activity of the preneoplastic marker enzyme gamma-glutamyl transpeptidase (gamma-GT), were determined in livers of CDD-treated and ad libitum-fed control animals. PEPCK activity showed evidence for dose-related inhibition on the second day after dosing; PC activity was slightly reduced, whereas gamma-GT activity was dose-dependently inhibited. By 8 days after dosing PEPCK activities were dose-dependently decreased after administration of all four CDDs and their mixture. PC activities were significantly reduced, but no dose-response was evident. The activity of gamma-GT was dose-dependently inhibited, but only to a value of 25% below control activities. It is concluded that CDDs share a common mechanism of acute toxicity, viz, inhibition of glucocorticoid-dependent enzymes which results in a derailment of intermediary metabolism not compatible with survival of the animals.lld:pubmed
pubmed-article:1359853pubmed:languageenglld:pubmed
pubmed-article:1359853pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:citationSubsetIMlld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1359853pubmed:statusMEDLINElld:pubmed
pubmed-article:1359853pubmed:issn0340-5761lld:pubmed
pubmed-article:1359853pubmed:authorpubmed-author:RozmanKKlld:pubmed
pubmed-article:1359853pubmed:authorpubmed-author:WeberL WLWlld:pubmed
pubmed-article:1359853pubmed:authorpubmed-author:KettrupAAlld:pubmed
pubmed-article:1359853pubmed:authorpubmed-author:LebofskyMMlld:pubmed
pubmed-article:1359853pubmed:authorpubmed-author:StahlB UBUlld:pubmed
pubmed-article:1359853pubmed:issnTypePrintlld:pubmed
pubmed-article:1359853pubmed:volume66lld:pubmed
pubmed-article:1359853pubmed:ownerNLMlld:pubmed
pubmed-article:1359853pubmed:authorsCompleteYlld:pubmed
pubmed-article:1359853pubmed:pagination478-83lld:pubmed
pubmed-article:1359853pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:meshHeadingpubmed-meshheading:1359853-...lld:pubmed
pubmed-article:1359853pubmed:year1992lld:pubmed
pubmed-article:1359853pubmed:articleTitleComparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part II: Structure-activity relationships with inhibition of hepatic phosphoenolpyruvate carboxykinase, pyruvate carboxylase, and gamma-glutamyl transpeptidase activities.lld:pubmed
pubmed-article:1359853pubmed:affiliationDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66160-7717.lld:pubmed
pubmed-article:1359853pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1359853pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1359853pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed